Warren S. Levy ,

MD, FACC
  • General Cardiology

Warren S. Levy is a board certified cardiologist with a special interest in coronary artery disease and risk modification including exercise and weight reduction.   

In addition to seeing patients at Virginia Heart, Dr. Levy directs a Physician Leadership Development Program through the Inova Health System and is a senior advisor for the Inova Heart and Vascular Institute. He is recognized locally and nationally for his expertise in cardiac care and serves on the leadership teams of several professional organizations. He is also often asked by the media to offer his expert opinion and commentary on stories related to cardiology.

Dr. Levy earned his medical degree with honors from the George Washington University School of Medicine, where he also completed his residency and fellowships in general and interventional cardiology. He became interested in medicine and cardiology while working his way through college at a Veterans Affairs hospital. During his career, he has specialized in both interventional and general cardiology.

To “walk the walk” of good cardiovascular care, Dr. Levy is an avid runner and skier—as long as his knees hold up. He cherishes time with his family, who bring him much pride and fulfillment. 

“The greatest joy and honor we have as physicians is to make a significant impact upon the lives of our patients and their families by improving their quality of life, their health and ultimately extending life through life-saving measures.”

 

Credentials

Medical School 

  • George Washington University School Of Medicine

Residency

  • George Washington University Medical Center | Internal Medicine

Fellowship

  • George Washington University Medical Center | Cardiovascular Disease

Board Certifications

  • Cardiovascular Disease
  • Internal Medicine

Specialty Areas of Interest

  • General Cardiology
  • Interventional Cardiology

Professional Associations

  • American College of Cardiology |  Fellow
  • Arlington County Medical Society
  • American Medical Association
  • Virginia State Medical Association
  • American College of Physicians
  • Alpha Omega Alpha

Teaching Positions

  • Clinical Assistant Professor of Medicine and Cardiology | Virginia Commonwealth University 
  • Clinical Assistant Professor of Medicine and Cardiology | University of Virginia

Recognitions

  • Top Doctor | Northern Virginia Magazine
  • Alpha Omega Alpha Medical Honor Society 

 Leadership Positions

  • Senior Advisor, Inova Schar Heart and Vascular Institute
  • Member, Steering Committee | MedAxiom
  • Director, Physician Leadership Development Program | Inova Schar Heart and Vascular Institute
  • Former Medical Director, Non-Invasive Cardiovascular Services | Virginia Hospital Center
  • Former Member, Medical Executive Committee | Virginia Hospital Center
  • Former Chair, Clinical Risk Management Committee | Virginia Hospital Center
  • Former Member, Medical Staff Executive Committee & Admissions Committee | George Washington University Medical Center

Other Languages Spoken

  • French

Hospital Affiliations

  • Virginia Hospital Center
  • Inova Alexandria Hospital
  • Inova Fair Oaks Hospital
  • Inova Fairfax Hospital
  • Reston Hospital Center

Publications

  • Levy WS, Katz RJ, Ross AM:  Limited Prognostic Value of Sub-maximal Exercise Testing  Following Non-Q Wave MI.  (Abst.) Circulation 1987; 76, IV-170.  (Presented at the 60th Annual Scientific Sessions, American Heart Association, November 1987.)
  • Morganroth J, Horowitz LN for the Encainide VT Research Group Levy, WS co- investigator)  Efficacy and Safety of Encainide in Life-Threatening Ventricular       Tachyarrythmias.  (Abst.)  Circulation 1987; 76, IV-368.
  • Levy WS, Katz RJ, Ruffalo RL, Leiboff RH, Wasserman AG:  Methionine Potentiates the Vasodilatory Effects of Nitroglycerin.  (Abst.)  J Am Col Card 1988; 11, 43A.  (Presented at the 37th Annual Scientific Sessions, American College of Cardiology, March 1988.)
  • Levy WS, Simon GL, Ross AM, Schulof RS, Rios JC: Clinically Silent Cardiac Abnormalities in Patients with HIV Infection.  (Abst.)  IV International Conference on AIDS, June, 1988, Stockholm, Sweden.
  • Levy WS, Varghese PJ, Anderson DW, Leiboff  RH, Orenstein JM, Virmani R, Bloom S: Myocarditis Diagnosed by Endomyocardial Biopsy in Human Immunodeficiency Virus Infection with Cardiac Dysfunction.  Am J Cardiol 1988; 62:658 – 659.
  • Levy Ws, Katz RJ, Ruffalo RL, Lieboff RH, Wasserman AG:  Potentiation of the Hemodynamic Effects of Acutely Administered Nitroglycerin by Methionine.  Circulation 1988;78: 640 - 645.
  • Levy WS, Simon GL, Rios JC, Ross Am:  Prevalence of Cardiac Abnormalities in Human Immunodeficiency Virus Infection.  Am J Cardiol 1989, 63: 86-89.
  • Levy WS, Simon GL, Rios JC, Ross AM:  Cardiac Abnormalities in Patients with Human Immunodeficiency Virus Infection.  (Abst.)  Circulation; 1988, 78:II-458.  (Presented at the 61st Annual Scientific Sessions, American Heart Association, November 1988.)
  • Levy WS, Katz RJ, Wasserman AG:  Methione Reverse Tolerance to Transdermal Nitroglycerin.  (Abst.)  J Am Coll. Cardiol 1989, 13:230A.  (Presented at the 38th Annual Scientific Sessions, American College of Cardiology, March 1989.)
  • The Encainide-Ventricular Tachycardia Study Group:  Treatment of Life-Threatening Ventricular Tachycardia with Encainide Hydrochloride in Patients with Left Ventricular Dysfunction.  (Levy WS:  Co-Investigator) Am J Cardiol 1988; 62:571-575.
  • Levy WS, Katz RJ, Buff L, Wasserman AG:  Nitroglycerin Tolerance is modified by Angiotensin Converting Enzyme Inhibitors (Abst.) Circulation 1989;80: II-214.  (Presented at the 62nd Annual Scientific Sessions, American Heart Association, November, 1989.)
  • Levy WS, Katz RJ, Wasserman AG:  Methionine Restores the Venodilative Response to Nitroglycerin after the Development of Tolerance. J Am Coll. Cardiol 1991;17:474-479.
  • Katz RJ, Levy WS, Wasserman AG:  Prevention of Nitrate Tolerance with Angiotensin Converting Enzyme Inhibitors. Circulation 1991;83: 1271-1277.
  • The Cardiac Arrhythmia Suppression Trial II Investigators:  Effect of the Antiarrhythmic Agent Moricizine on Survival after Myocardial Infarction.  (Levy, WS:  Co-Investigator)  New England Jour Med. 1992;327:227-223.
  • The GUSTO Investigators: An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction.  (Levy, WS:  Co-Investigator) New England Jour Med. 1993; 329:673-82.
  • O’Connor FG, Levy WS, Oriscello RG, Wilder RP:  Asymptomatic Aortic Insufficiency in a Runner.  The Physician and Sports Medicine 1995; 23:33-42.
Levy

"The greatest joy and honor as a physician is when we have the opportunity to make a significant impact upon the lives of our patients and their families -- both when life saving measures are needed and in quality of life."

- Dr. Warren S. Levy

Patient Testimonial